Occupational health and TB

Dr. Dalene von Delft developed active MDR-TB while working as a physician in 2010. Video by RESULTS.

Need for New Drugs for Pediatric TB - Little Stars with TB Scars

Raising awareness of the unique troubles pediatric TB patients face when seeking cure. Video by Pushpdeep Mishra.

Multidrug-Resistance Tuberculosis: No Promises

The most neglected MDR-TB victims are children Photo’s Ron Haviv visited MSF’s pediatric MDR-TB program in Tajikistan to document this new and very dangerous medical front line. Video from MSF.

I am the Voice of TB

Together, we are the voice of the TB community, and together, we are fighting for a TB-free world.

An American Woman's Battle with Latent TB

Too many TB patients live in silence. Expanding the dialogue about the disease is a source of comfort and empowerment.

TB Alliance 2012: Realizing the Promise

TB Alliance President & CEO, Dr. Mel Spigelman looks back at the successes of 2012 and toward the future of TB drug development

Unlocking the path to 2-week therapy

Dr. Khisi Mduli on how TB Alliance identifies regimens for development, and the existing scientific barriers to 2-week TB therapy.

South Africa at the Forefront: TB trials at Stellenbosch University

Dr. Andreas Diacon discusses the numerous collaborations between the TB Alliance and the University of Stellenbosch in South Africa.

Engaging Communities in Nigeria

Mayowa Joel discusses efforts to further strengthen community engagement in TB research and development efforts.

Without Community, Research is not Possible

John Mduli of the Aurum Institute explains the importance of engaging and gaining the acceptance of local communities in research

CPTR, TB Alliance, and the future of TB R&D Funding

Dr. Jan Gheuens of the Bill & Melinda Gates Foundation on the importance of CPTR and the TB Alliance and the future TB research funding landscape.

Dr. Anthony Fauci on the Importance of Combination Development

US NIAID Director, Dr. Anthony Fauci speaks on the importance of testing new TB drugs in combination to accelerate the development of new, effective drugs that can stem the tide of TB and drug-resistant TB.

The Gates Foundation and the Fight Against Tuberculosis

Dr. Neil Schluger of Columbia University on the impact of Gates Foundation on TB research, and the prospects of financing this work long term. (Courtesy of BigThink)

Voice of America's Coverage of NC-002 Trial Launch

US Government representatives speak on the promise of NC-002 and the new generation of TB research underway at the TB Alliance and around the world.

Tackling TB: Developing the First Novel Drug Regimen

A study published in The Lancet shows TB Alliance new drug regimen could be a life-changer for patients

Addressing the Large and Messy Private TB Drug Market

Addressing the inconsistencies of TB treatment in the private sector will be critical to protecting new TB drugs.

Dr. Margaret Hamburg on the Promise of CPTR

It’s time to wake up from hibernation!

TB Alliance: A Decade of Innovation

How the TB Alliance transformed the TB drug R&D landscape from barren to bustling.

Critical Path to TB Drug Regimens

Inside the workings of the revolutionary CPTR initiative and the innovative scientific models it promotes

“My grandson, he’s a warrior!”

Watch as a brave 7-year old battle MDR-TB

An American’s Story

Some of our best lessons we learn from children.

Winstone Zulu Lives through his Work

Winstone Zulu was the first man in Southern Africa to publicly declare himself HIV positive. He devoted his life to advocating for HIV- and TB-related causes. Winstone died on October 12, 2011

Pediatric TB and Communities

Pediatric TB is a barometer of TB burden throughout a community.

New Promise from a Familiar Class

Riminophenazines show potential as next-generation TB drugs

Treating TB Patients in New Jersey

TB is not just a developing world issue; Rebecca is on the frontlines of TB treatment… in New Jersey.

SABC Coverage of NC001

Local coverage in South Africa of the world's first novel TB regimen clinical trial.

Borders Don’t Apply to Bugs

Why we should all care about MDR- and XDR-TB.

Empowering TB/HIV Patients in Kenya

Introducing the TB Alliance’s Stakeholders Association Patient Representative.

MDR-TB Outbreak NYC: Lessons Learnt

What an MDR-TB outbreak in New York taught us about public health responses and TB awareness.

History in the making

Wally J is taking part in the world's first novel TB regimen development clinical trial.

Galvanizing TB Advocacy in India

Empowering individuals to tell their leaders what they feel is important.

Fighting TB in Brazil

On a quest to shed the “high-burden” tag.

Scientific Challenges of TB Drug Development

What makes developing drugs for TB uniquely challenging?

The Man Behind the “Denver TB Course”

“We have gone about as far with the available drugs as we can go.”

The Need for New TB Drugs

Why new drugs are so critical to the fight against TB.

A Decade of Innovation

The past and present CEOs of the TB Alliance on what it takes to succeed.

Spreading the Message

From patient to powerhouse, Lucy speaks on the need to develop new tools to fight TB.

TB Story on La 2 Noticias

Patient advocate and TB R&D activist, Lucy Chesire, is interviewed as part of a story on TB for Spanish-language La 2 Noticas television.

CC-TV Coverage of GHRC Launch

Chinese-language coverage of the signing of the Memorandum of Understanding between the TB Alliance and International Scientific Exchange Foundation of China.